Use of Implanted Antitachycardia Pacemakers to Treat Paroxysmal Atrial Flutter

  1. ALBERT L. WALDO, M.D.;
  2. BRIAN OLSHANSKY, M.D.; and
  3. RICHARD W. HENTHORN, M.D.
  1. Case Western Reserve University/University Hospitals of Cleveland,
    Cleveland, Ohio

    Excerpt

    We believe that the article in the current issue by Barold and colleagues (1) has great value in that it serves to illustrate not only the long-term efficacy of an antitachycardia pacemaker to treat recurrent atrial flutter in selected patients, but also, as reflected by the fact that the five patients in the study were being treated at three different centers, that the technique is underutilized.

    The fact that type I (classical) atrial flutter should always be amenable to treatment involving the use of rapid atrial pacing techniques now seems well established. As has been summarized by Barold and colleagues

    This 100-word excerpt has been provided in the absence of an abstract.

    Acknowledgments

    ACKNOWLEDGMENTS: Grant support: in part by grant HL38408 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; and a Research Initiative Award from the American Heart Association, Northeast Ohio Affiliate, Cleveland, Ohio.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement